MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis

被引:0
|
作者
Vladimir Vasku
Julie Bienertova-Vasku
Miroslav Necas
Anna Vasku
机构
[1] Masaryk University Brno,1st Department of Dermatology, St. Ann’s Faculty Hospital
[2] Masaryk University,Department of Pathophysiology, Faculty of Medicine
来源
关键词
MTHFR; Polymorphism; Psoriasis; Folate; DNA methylation;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (Pg = 0.03) and allelic frequency (Pa = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12–2.15, P = 0.004814, Pcorr = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (Pa = 0.02) and in those with a frequent tonsillitis/tonsillectomy (Pa = 0.04). No difference was observed between patients with and without positive family history of psoriasis (Pa = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33–7.56, Pcorr = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.
引用
收藏
页码:327 / 331
页数:4
相关论文
共 50 条
  • [41] Distribution of alleles of the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in familial spina bifida
    Johnson, WG
    Stenroos, ES
    Heath, SC
    Chen, YP
    Carroll, R
    McKoy, VV
    Chatkupt, S
    Lehner, T
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 87 (05): : 407 - 412
  • [42] Comparison of the Frequency of the Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism in Depressed Versus Nondepressed Patients
    Lizer, Mitsi H.
    Bogdan, Renee L.
    Kidd, Robert S.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2011, 17 (06) : 404 - 409
  • [43] The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
    Masataka Shiraki
    Tomohiko Urano
    Tatsuhiko Kuroda
    Mitsuru Saito
    Shiro Tanaka
    Mariko Miyao-Koshizuka
    Satoshi Inoue
    Journal of Bone and Mineral Metabolism, 2008, 26 : 595 - 602
  • [44] The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and bone mineral density in postmenopausal women in Malta
    Vidal, C
    Brincat, M
    Xuereb-Anastasi, A
    BONE, 2005, 36 : S245 - S246
  • [45] Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis
    Vandana Rai
    Molecular Neurobiology, 2017, 54 : 1173 - 1186
  • [46] Effect of the Polymorphism C677T Methylenetetrahydrofolate Reductase (MTHFR) in the Follow-up of Colorectal Cancer
    Delgado-Plasencia, L.
    Gonzalez-Garcia, S.
    Medina-Arana, V.
    Perez-Palma, J.
    Alvarez-Argueelles Cabrera, H.
    Salido-Ruiz, E.
    Fernandez-Peralta, A.
    Gonzalez-Aguilera, J. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S128 - S128
  • [47] Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Subacute Combined Degeneration: Revealing a Genetic Predisposition
    Zhang, Xin
    Hou, Chen
    Liu, Peng
    Chen, Li
    Liu, Yue
    Tang, Peng
    Li, Rui
    FRONTIERS IN NEUROLOGY, 2019, 9
  • [48] Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility
    Vandana Rai
    Metabolic Brain Disease, 2016, 31 : 727 - 735
  • [49] Genomic DNA hypomethylation in homozygotes for the C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene.
    Stern, LL
    Choi, SW
    Mason, JB
    Selhub, J
    FASEB JOURNAL, 1999, 13 (04): : A373 - A373
  • [50] Smoking behavior and the C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene
    Johnson, WG
    Spychala, JR
    Stenroos, ES
    Scholl, TO
    Schroeder, CM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 98 (04): : 361 - 362